Objective: Cytomegalovirus (CMV) is widely distributed and constitutes the main cause of congenital infections worldwide. CMV transmission during pregnancy represents one of the major impacts of this virus on public health. This study aimed at assessing glycoprotein B (gB) CMV genotypes in Mexican children and pregnant women, since there is limited information regarding CMV genomic diversity in Mexico. Methods: We analyzed CMV strains detected in Mexican children (n = 38) and women (n = 38) between 2001 and 2012. A fragment of the gB gene was amplified and sequenced, and genotypes were defined based on prototype sequences. Results: The gB1 genotype was detected more frequently in children (68.4%) compared to women (31.6%; p = 0.0028), while genotype 2 was more common in women (65.8%) compared to children (26.3%, p = 0.0012). Genotype 3 was uncommon in both groups (5.3 and 2.6%). Nucleotide sequences exhibited a high degree of similarity to prototype strains. However, we identified 17 distinct sequences that resulted in changes in the encoded amino acid sequence in four strains. Conclusions: gB1 and gB2 are the most common strains associated with CMV infection in Mexican children and women. In addition, we found that the frequency for each genotype differed amongst them, possibly due to variability in transmission or reactivation dynamics.

1.
Stagno S: Cytomegalovirus; in Remington JS, Klein JO (eds): Infectious Diseases of the Fetus and Newborn Infant, ed 5. Philadelphia, Saunders, 2001, pp 389-424.
2.
Dollard SC, Grosse SD, Ross DS: New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007;17:355-363.
3.
Bale JF Jr, Murph JR, Demmler GJ, Dawson J, Miller JE, Petheram SJ: Intrauterine cytomegalovirus infection and glycoprotein B genotypes. J Infect Dis 2000;182:933-936.
4.
Drew WL, Chou S, Miner RC, Mohr BA, Busch MP, van der Horst CM, Asmuth DM, Kalish LA: Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis. J Infect Dis 2002;186:114-117.
5.
Humar A, Kumar D, Gilbert C, Boivin G: Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease. J Infect Dis 2003;188:581-584.
6.
Shepp DH, Match ME, Ashraf AB, Lipson SM, Millan C, Pergolizzi R: Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J Infect Dis 1996;174:184-187.
7.
Monsivais-Urenda A, Noyola-Cherpitel D, Hernandez-Salinas A, Garcia-Sepulveda C, Romo N, Baranda L, Lopez-Botet M, Gonzalez-Amaro R: Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children. Eur J Immunol 2010;40:1418-1427.
8.
Chou SW, Dennison KM: Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 1991;163:1229-1234.
9.
Faure-Della Corte M, Samot J, Garrigue I, Magnin N, Reigadas S, Couzi L, Dromer C, Velly JF, Dechanet-Merville J, Fleury HJ, Lafon ME: Variability and recombination of clinical human cytomegalovirus strains from transplantation recipients. J Clin Virol 2010;47:161-169.
10.
Meyer-König U, Haberland M, von Laer D, Haller O, Hufert FT: Intragenic variability of human cytomegalovirus glycoprotein B in clinical strains. J Infect Dis 1998;177:1162-1169.
11.
Pignatelli S, Dal Monte P, Rossini G, Landini MP: Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev Med Virol 2004;14:383-410.
12.
Pignatelli S, Dal Monte P, Rossini G, Lazzarotto T, Gatto MR, Landini MP: Intrauterine cytomegalovirus infection and glycoprotein N (gN) genotypes. J Clin Virol 2003;28:38-43.
13.
Roubalova K, Strunecky O, Vitek A, Zufanova S, Prochazka B: Genetic variability of cytomegalovirus glycoprotein O in hematopoietic stem cell transplant recipients. Transpl Infect Dis 2011;13:237-243.
14.
Waters A, Hassan J, De Gascun C, Kissoon G, Knowles S, Molloy E, Connell J, Hall WW: Human cytomegalovirus UL144 is associated with viremia and infant development sequelae in congenital infection. J Clin Microbiol 2010;48:3956-3962.
15.
Arista S, De Grazia S, Giammanco GM, Di Carlo P, Iannitto E: Human cytomegalovirus glycoprotein B genotypes in immunocompetent, immunocompromised, and congenitally infected Italian populations. Arch Virol 2003;148:547-554.
16.
Baldanti F, Paolucci S, Campanini G, Sarasini A, Percivalle E, Revello MG, Gerna G: Human cytomegalovirus UL131A, UL130 and UL128 genes are highly conserved among field isolates. Arch Virol 2006;151:1225-1233.
17.
Bergallo M, Costa C, Gambarino S, Tornicelli A, Astegiano S, Terlizzi ME, Solidoro P, Cavallo R: Human cytomegalovirus glycoprotein B genotyping from bronchoalveolar lavage specimens. Can J Microbiol 2011;57:273-277.
18.
Correia-Silva JF, Resende RG, Arao TC, Abreu MH, Teixeira MM, Bittencourt H, Silva TA, Gomez RS: HCMV gB genotype and its association with cytokine levels in hematopoietic stem cell transplantation. Oral Dis 2011;17:530-537.
19.
de Vries JJ, Wessels E, Korver AM, van der Eijk AA, Rusman LG, Kroes AC, Vossen AC: Rapid genotyping of cytomegalovirus in dried blood spots by multiplex real-time PCR assays targeting the envelope glycoprotein gB and gH genes. J Clin Microbiol 2012;50:232-237.
20.
de Campos Dieamant D, Bonon SH, Prates LC, Belangelo VM, Pontes ER, Costa SC: Active human cytomegalovirus infection and glycoprotein B genotypes in Brazilian pediatric renal or hematopoietic stem cell transplantation patients. Braz J Microbiol 2010;41:50-58.
21.
González-Ramírez J, Uribe-Gutiérrez G, Jiménez-Hernandez E, Velázquez-Guadarrama N, Bello-González A, Vazquez-Meraz E, Arellano-Galindo J: Cytomegalovirus gB genotype distribution in Mexican children undergoing allogeneic bone marrow transplantation. Intervirology 2012;50:318-320.
22.
Manuel O, Asberg A, Pang X, Rollag H, Emery VC, Preiksaitis JK, Kumar D, Pescovitz MD, Bignamini AA, Hartmann A, Jardine AG, Humar A: Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease. Clin Infect Dis 2009;49:1160-1166.
23.
Rasmussen L, Hong C, Zipeto D, Morris S, Sherman D, Chou S, Miner R, Drew WL, Wolitz R, Dowling A, Warford A, Merigan TC: Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. J Infect Dis 1997;175:179-184.
24.
Rosen HR, Corless CL, Rabkin J, Chou S: Association of cytomegalovirus genotype with graft rejection after liver transplantation. Transplantation 1998;66:1627-1631.
25.
Torok-Storb B, Boeckh M, Hoy C, Leisenring W, Myerson D, Gooley T: Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation. Blood 1997;90:2097-2102.
26.
Xia CS, Zhao XT, Sun YY, Zhang Z: Human cytomegalovirus glycoprotein B genotypes in chinese hematopoietic stem cell transplant recipients. Intervirology 2012;55:342-348.
27.
Zhou L, Fan J, Zheng SS, Ma WH: Genetic variation within the glycoprotein B and H genes of human cytomegalovirus in solid organ transplant recipients. Transpl Infect Dis 2007;9:73-77.
28.
Chern KC, Chandler DB, Martin DF, Kuppermann BD, Wolitz RA, Margolis TP: Glycoprotein B subtyping of cytomegalovirus (CMV) in the vitreous of patients with AIDS and CMV retinitis. J Infect Dis 1998;178:1149-1153.
29.
Cunha AA, Aquino VH, Mariguela V, Nogueira ML, Figueiredo LT: Evaluation of glycoprotein B genotypes and load of CMV infecting blood leukocytes on prognosis of AIDS patients. Rev Inst Med Trop Sao Paulo 2011;53:82-88.
30.
Fidouh-Houhou N, Duval X, Bissuel F, Bourbonneux V, Flandre P, Ecobichon JL, Jordan MC, Vilde JL, Brun-Vezinet F, Leport C: Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patients. Clin Infect Dis 2001;33:1406-1411.
31.
Gilbert C, Handfield J, Toma E, Lalonde R, Bergeron MG, Boivin G: Human cytomegalovirus glycoprotein B genotypes in blood of AIDS patients: lack of association with either the viral DNA load in leukocytes or presence of retinitis. J Med Virol 1999;59:98-103.
32.
Peek R, Verbraak F, Bruinenberg M, Van der Lelij A, Van den Horn G, Kijlstra A: Cytomegalovirus glycoprotein B genotyping in ocular fluids and blood of AIDS patients with cytomegalovirus retinitis. Invest Ophthalmol Vis Sci 1998;39:1183-1187.
33.
Tarrago D, Quereda C, Tenorio A: Different cytomegalovirus glycoprotein B genotype distribution in serum and cerebrospinal fluid specimens determined by a novel multiplex nested PCR. J Clin Microbiol 2003;41:2872-2877.
34.
Ross SA, Novak Z, Pati S, Patro RK, Blumenthal J, Danthuluri VR, Ahmed A, Michaels MG, Sanchez PJ, Bernstein DI, Tolan RW, Palmer AL, Britt WJ, Fowler KB, Boppana SB: Mixed infection and strain diversity in congenital cytomegalovirus infection. J Infect Dis 2011;204:1003-1007.
35.
Murthy S, Hayward GS, Wheelan S, Forman MS, Ahn JH, Pass RF, Arav-Boger R: Detection of a single identical cytomegalovirus (CMV) strain in recently seroconverted young women. PLoS One 2011;6:e15949.
36.
Zipeto D, Hong C, Gerna G, Zavattoni M, Katzenstein D, Merigan TC, Rasmussen L: Geographic and demographic differences in the frequency of human cytomegalovirus gB genotypes 1-4 in immunocompromised patients. AIDS Res Hum Retroviruses 1998;14:533-536.
37.
Gorzer I, Kerschner H, Redlberger-Fritz M, Puchhammer-Stockl E: Human cytomegalovirus (HCMV) genotype populations in immunocompetent individuals during primary HCMV infection. J Clin Virol 2010;48:100-103.
38.
Terabe K, Sugiyama K, Goto K, Mizutani F, Wada Y, Yokoyama T, Ando Y: Relationship between human cytomegalovirus glycoprotein B genotype and serum alanine aminotransferase elevation in infants. Tohoku J Exp Med 2004;203:339-344.
39.
Yan H, Koyano S, Inami Y, Yamamoto Y, Suzutani T, Mizuguchi M, Ushijima H, Kurane I, Inoue N: Genetic variations in the gB, UL144 and UL149 genes of human cytomegalovirus strains collected from congenitally and postnatally infected Japanese children. Arch Virol 2008;153:667-674.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.